Asia
Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.
Under terms of the deal, Aurobindo would pay $900 million upfront with an additional $100 million in milestone payments. However, in a filing with the Securities and Exchange Commission, the company announced it had terminated that agreement.
Biopharma companies from across the globe provide updates on their pipelines and business practices.
The companies initiated a Phase II/III trial in Italy, Spain, Germany, France, Japan, Canada and Russia.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.
Sartorius has supported CanSino Biologics Inc. and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials.
The two companies plan to focus their efforts on targeting several rare diseases.
Although some clinical trials are being slowed or halted, others are reporting out data. Here’s a look.
Difamilast is a novel atopic dermatitis compound discovered by Otsuka.
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
PRESS RELEASES